Requirement for Binding Multiple Atps to Convert a Groel Ring to the Folding-Active State

Total Page:16

File Type:pdf, Size:1020Kb

Requirement for Binding Multiple Atps to Convert a Groel Ring to the Folding-Active State Requirement for binding multiple ATPs to convert a GroEL ring to the folding-active state Eli Chapmana, George W. Farrb,c, Wayne A. Fentonc, Steven M. Johnsona, and Arthur L. Horwicha,b,c,1 aThe Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037; and bHoward Hughes Medical Institute and cDepartment of Genetics, Yale School of Medicine, Boyer Center, 295 Congress Avenue, New Haven, CT 06510 Contributed by Arthur L. Horwich, October 22, 2008 (sent for review October 9, 2008) Production of the folding-active state of a GroEL ring involves reflected in a structure of GroEL–GroES–ADP–AlF3 (11), initial cooperative binding of ATP, recruiting GroES, followed by affords a critical level of energy and cooperativity. large rigid body movements that are associated with ejection of The question remains, however, of how many subunits must bound substrate protein into the encapsulated hydrophilic cham- cooperatively bind ATP to recruit the collective of subunits in a ber where folding commences. Here, we have addressed how ring to the folding-active state. For example, does binding a many of the 7 subunits of a GroEL ring are required to bind ATP to single ATP to a ring bring about such movement and activation drive these events, by using mixed rings with different numbers of of folding? Or, at the other extreme, is there a requirement to wild-type and variant subunits, the latter bearing a substitution in bind ATP to each subunit to produce the collective movement the nucleotide pocket that allows specific block of ATP binding and that activates folding? In other words, how redundant is the turnover by a pyrazolol pyrimidine inhibitor. We observed that at system with respect to its ATP requirement? Here, we have been least 2 wild-type subunits were required to bind GroES. By con- able to address this question by using a small-molecule chemical trast, the triggering of polypeptide release and folding required a inhibitor that specifically blocks ATP binding and hydrolysis by minimum of 4 wild-type subunits, with the greatest extent of a subunit variant containing an amino acid substitution in the refolding observed when all 7 subunits were wild type. This is GroEL nucleotide pocket. Using mixed rings composed of both consistent with the requirement for a ‘‘power stroke’’ of forceful wild-type and variant subunits, the chemical compound, and apical movement to eject polypeptide into the chamber. ATP, we could assess the number of subunits required for steps of both GroES association and triggering productive folding. ͉ ͉ ͉ ͉ chaperonin chemical inhibitor nucleotide protein folding Results pyrazolol pyrimidine A Pyrazolol Pyrimidine Competitively Blocks ATP Binding and Hydro- lysis by a GroEL Variant Substituted in the Nucleotide Pocket, I493C. n the cell, ATP and GTP are ubiquitously used as molecular To investigate the number of subunits in a GroEL ring that must Itriggers that drive a host of cellular functions. In particular, bind ATP to activate folding, we sought a small molecule ATP drives the final step of information transfer for many genes, inhibitor that could specifically prevent binding of ATP to a the step of chaperonin-mediated protein folding (1, 2). The variant GroEL subunit. This would enable probing mixed rings GroEL double ring machine, for example, is directed into its containing various proportions of variant and wild-type subunits folding-active state by the concerted binding of ATPs to the 7 in the presence of inhibitor to assess the requirements for ATP subunits of a substrate polypeptide-bound ring (3). ATP binding binding in driving GroES association and in initiating productive in the equatorial domains of these subunits drives rigid body folding. The strategy used for isolating an orthogonal inhibitor– movements of the apical domains, which bear the hydrophobic variant GroEL pair corresponded to that implemented by polypeptide-binding surface lining the opening to a ring (4, 5). Shokat and coworkers in studying actions of specific protein In particular, small ATP-directed elevation and twisting move- kinases (21): side chains at the position of the base in the GroEL BIOCHEMISTRY ments serve to recruit the cochaperonin lid structure, GroES (6). nucleotide pocket were shortened to alanine or cysteine, and a This triggers further large movements of the apical domains, variety of pyrazolol pyrimidine derivatives were then tested for Ϸ60° elevation and Ϸ120° clockwise twist, that release the the ability to block ATP hydrolysis in vitro by the purified substrate protein off the dislocating hydrophobic surface, effec- homooligomeric GroEL variants (E.C., G.W.F., K. Furtak, and tively ejecting the substrate into a hydrophilic GroES- A.L.H., unpublished work). Strong inhibition of hydrolysis was encapsulated chamber where productive folding ensues (4, 5, obtained with a variant, I493C, and a cyclopentane-carboxamide 7–14). This step of ATP-mediated activation requires less than derivative, EC3016 [Fig. 1 A and B; see supporting information 1 s (9, 12). Productive folding then proceeds for Ϸ10 s followed (SI) Methods and Fig. S1 for synthesis). by ATP hydrolysis and subsequent ATP binding to the opposite I493C behaved as a bona fide variant of GroEL. In vivo, ring, which leads to rapid dissociation of GroES and substrate expression of the variant from a trc promoter-driven GroESL protein (Ͻ1 s) (9, 15). operon carried on a pBR322 plasmid in the absence of induction ATP is specifically required for the activation of folding (16, led to a level of I493C GroEL corresponding to the normal level 17), with ADP unable to support release of polypeptide into the of chromosomally expressed wild-type GroEL, and this pro- folding chamber despite the ability to produce the movements duced rescue of GroEL-deficient LG6 cells (22). In addition, the that enable stable binding of GroES (7, 9, 11, 18). In particular, the apical domains of GroEL are observed to move more slowly Author contributions: E.C. and A.L.H. designed research; E.C., G.W.F., W.A.F., S.M.J., and in the presence of bound substrate protein during the formation A.L.H. performed research; E.C. contributed new reagents/analytic tools; E.C., W.A.F., of ADP–GroES complexes, failing to release the substrate, S.M.J., and A.L.H. analyzed data; and E.C. and A.L.H. wrote the paper. reflecting that ADP-driven movements may not be as forceful The authors declare no conflict of interest. (18). In addition, ATP binds cooperatively to GroEL whereas Freely available online through the PNAS open access option. ADP does not (19). GroEL mutations that abolish this cooper- 1To whom correspondence should be addressed. E-mail: [email protected]. ative action of ATP reduce the rate of productive folding (20). This article contains supporting information online at www.pnas.org/cgi/content/full/ Thus, the presence of the ␥-phosphate, conferring a host of 0810657105/DCSupplemental. hydrogen bonds with the surrounding nucleotide pocket, as © 2008 by The National Academy of Sciences of the USA www.pnas.org͞cgi͞doi͞10.1073͞pnas.0810657105 PNAS ͉ December 9, 2008 ͉ vol. 105 ͉ no. 49 ͉ 19205–19210 Downloaded by guest on September 29, 2021 1B) because it allowed easy detection of this subunit in coex- pression studies by its faster migration than I493C in SDS/ PAGE. 532⌬ exhibits a slightly reduced rate of steady-state ATP turnover relative to nondeleted GroEL, as expected based on recent observations that steady-state ATP turnover scales approximately with C terminus tail length of GroEL (23). If anything, EC3016 slightly stimulated the rate of steady-state turnover of both wild- type and 532⌬. This may be a function of nonspecific association of the inhibitor with the hydrophobic polypeptide-binding surface of the GroEL apical domains, leading to allosteric activation of ATP turnover. Consistent with such behavior, we observed that virtually all of the other pyrazolol pyrimidine compounds produced the same mild stimulation of GroEL ATPase activity. To address further the nature of inhibition by EC3016, initial rates of ATP hydrolysis were measured with varying concentra- tions of ATP and EC3016, plotted as a set of curves in Fig. 1C. For each curve, the pattern of increasing rate of turnover with respect to ATP concentration followed by a decrease fits the nested-cooperativity model originally proposed by Yifrach and Horovitz (3), entailing cooperative binding of ATP within a GroEL ring and negative cooperativity between rings. Thus, cooperative ATP binding is maintained by I493C subunits. With increasing concentration of EC3016 compound, the curves were progressively displaced downward. Extensive modeling of the data supported a mechanism of competitive inhibition, but other models cannot be completely excluded. Consistent, however, with the notion that inhibition occurs at the level of competition for the nucleotide pocket, steady-state turnover by a single ring version of I493C was also strongly inhibited by EC3016 (Fig. 1D). Mixed-Ring Assemblies Containing Various Proportions of Wild-Type and I493C Subunit. To analyze requirements for ATP binding, we programmed expression of mixed-ring GroEL complexes con- taining various proportions of 532⌬ subunits and I493C subunits from separate plasmids with either ara or trc promoters (Fig. 2). This was accomplished by varying the relative levels of induction with different concentrations of arabinose and IPTG in the medium (Fig. 2). Relative induction levels were adjusted based on analyses in SDS/PAGE, where 532⌬ migrated faster than I493C. The complexes from cultures with various relative levels of induction were then purified chromatographically and, to determine more precisely the relative content of the 2 different subunits, mass spectrometry (MS) was carried out on the purified complexes employing ‘‘standards’’ produced by mixing different relative known amounts of purified homooligomers of 532⌬ and I493C (see, for example, Fig.
Recommended publications
  • Review Article Functional Subunits of Eukaryotic Chaperonin CCT/Tric in Protein Folding
    SAGE-Hindawi Access to Research Journal of Amino Acids Volume 2011, Article ID 843206, 16 pages doi:10.4061/2011/843206 Review Article Functional Subunits of Eukaryotic Chaperonin CCT/TRiC in Protein Folding M. Anaul Kabir,1 Wasim Uddin,1 Aswathy Narayanan,1 Praveen Kumar Reddy,1 M. Aman Jairajpuri,2 Fred Sherman,3 and Zulfiqar Ahmad4 1 Molecular Genetics Laboratory, School of Biotechnology, National Institute of Technology Calicut, Kerala 673601, India 2 Department of Biosciences, Jamia Millia Islamia, Jamia Nagar, New Delhi 110025, India 3 Department of Biochemistry and Biophysics, University of Rochester Medical Center, NY 14642, USA 4 Department of Biology, Alabama A&M University, Normal, AL 35762, USA Correspondence should be addressed to M. Anaul Kabir, [email protected] Received 15 February 2011; Accepted 5 April 2011 Academic Editor: Shandar Ahmad Copyright © 2011 M. Anaul Kabir et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Molecular chaperones are a class of proteins responsible for proper folding of a large number of polypeptides in both prokaryotic and eukaryotic cells. Newly synthesized polypeptides are prone to nonspecific interactions, and many of them make toxic aggregates in absence of chaperones. The eukaryotic chaperonin CCT is a large, multisubunit, cylindrical structure having two identical rings stacked back to back. Each ring is composed of eight different but similar subunits and each subunit has three distinct domains. CCT assists folding of actin, tubulin, and numerous other cellular proteins in an ATP-dependent manner.
    [Show full text]
  • Structure, Hormonal Regulation and Chromosomal Location of Genes Encoding Barley (1-+A)-B-Xylan Endohydrolases
    l;),, (!. s,9 47 STRUCTURE, HORMONAL RB,GULA CHROMOSOMAL LOCATION OF GENES ENCODING BARLEY (1+4)- p-XYLAI\ ENDOHYDROLASES by MITALI BANIK, B.Sc. (Hons.), M.Sc. A thesis submitted in fulfillment of the requirement for the degree of Doctor of Philosophy Department of Plant Science, Division of Agricultural and Natural Resource Sciences, TheUniversity of Adelaide, Waite Campus, Glen Osmond,5064 Australia October, 1996 1l STATEMENT OF AUTHORSHIP Except where reference is made in the text of the thesis, this thesis contains no material published elsewhere or extracted in whole or in part from a thesis presented by me for another degree or diploma. No other person's work has been used without due acknowledgment in the main text of the thesis. This thesis has not been submitted for the award of any other degree or diploma in any other tertiary institution. MITALI BANIK October, 1996 o lll ACKNOWLBDGMENTS I would like to express my deepest sense of gratitude and indebtedness to my supervisor, Professor Geoffrey B. Fincher, Head of Department, Plant Science, University of Adelaide for his constant guidance, infinite patience, encouragement and invaluable suggestions throughout my studies. I wish to express my immense gratitude to Professor Derek Bewley, Department of Botany, University of Guelph, Canada for his constructive criticism during the preparation of this thesis. I am also grateful to Drs. Frank Gubler and John V. Jacobsen, CSIRO Division of Plant Industry, Canberra for providing a cDNA library. I wish to thank Dr. Simon Robinson, Senior Scientist, CSIRO for his constructive suggestions throughout the duration of my research project.
    [Show full text]
  • The Chaperonin Folding Machine
    Review TRENDS in Biochemical Sciences Vol.27 No.12 December 2002 627 32 He, B. et al. (1998) Glycogen synthase kinase 3β DNA damage-induced phosphorylation. Science regulates transcriptional activity. Mol. Cell 6, and extracellular signal-regulated kinase 292, 1910–1915 539–550 inactivate heat shock transcription factor 1 by 43 Waterman, M.J. et al. (1998) ATM-dependent 53 Beals, C.R. et al. (1997) Nuclear localization of facilitating the disappearance of transcriptionally activation of p53 involves dephosphorylation and NF-ATc by a calcineurin-dependent, active granules after heat shock. Mol. Cell. Biol. association with 14-3-3 proteins. Nat. Genet. 19, cyclosporin-sensitive intramolecular interaction. 18, 6624–6633 175–178 Genes Dev. 11, 824–834 33 Xia, W. et al. (1998) Transcriptional activation of 44 Stavridi, E.S. et al. (2001) Substitutions that 54 Porter, C.M. et al. (2000) Identification of amino heat shock factor HSF1 probed by phosphopeptide compromise the ionizing radiation-induced acid residues and protein kinases involved in the analysis of factor 32P-labeled in vivo. J. Biol. association of p53 with 14-3-3 proteins also regulation of NFATc subcellular localization. Chem. 273, 8749–8755 compromise the ability of p53 to induce cell cycle J. Biol. Chem. 275, 3543–3551 34 Dai, R. et al. (2000) c-Jun NH2-terminal kinase arrest. Cancer Res. 61, 7030–7033 55 Yang, T.T. et al. (2002) Phosphorylation of NFATc4 targeting and phosphorylation of heat shock 45 Kaeser, M.D. and Iggo, R.D. (2002) Chromatin by p38 mitogen-activated protein kinases. factor-1 suppress its transcriptional activity.
    [Show full text]
  • Technische Universität München
    TECHNISCHE UNIVERSITÄT MÜNCHEN Department Chemie Lehrstuhl für Biotechnologie Analysis of small heat shock proteins and their interaction with substrate proteins Marina Angelika Kreuzeder Vollständiger Abdruck der von der Fakultät für Chemie der Technischen Universität München zur Erlangung des akademischen Grades eines Doktors der Naturwissenschaften (Dr. rer. nat.) genehmigten Dissertation. Vorsitzender: Prof. Dr. Bernd Reif Prüfer der Dissertation 1. Prof. Dr. Johannes Buchner 2. Prof. Dr. Michael Sattler Die Dissertation wurde am 18.09.2017 bei der Technischen Universität München eingereicht und durch die Fakultät für Chemie am 02.11.2017 angenommen. Für meine Eltern Contents Contents 1. INTRODUCTION.............................................................................................. 1 1.1 Protein folding .................................................................................................................................. 1 1.2 Cell stress and heat shock proteins ........................................................................................... 3 1.3 Molecular chaperones .................................................................................................................... 5 1.4 ATP- dependent chaperones ........................................................................................................ 6 1.5 Small heat shock proteins ............................................................................................................. 9 1.5.1 Structure of Hsps .....................................................................................................................................
    [Show full text]
  • 12) United States Patent (10
    US007635572B2 (12) UnitedO States Patent (10) Patent No.: US 7,635,572 B2 Zhou et al. (45) Date of Patent: Dec. 22, 2009 (54) METHODS FOR CONDUCTING ASSAYS FOR 5,506,121 A 4/1996 Skerra et al. ENZYME ACTIVITY ON PROTEIN 5,510,270 A 4/1996 Fodor et al. MICROARRAYS 5,512,492 A 4/1996 Herron et al. 5,516,635 A 5/1996 Ekins et al. (75) Inventors: Fang X. Zhou, New Haven, CT (US); 5,532,128 A 7/1996 Eggers Barry Schweitzer, Cheshire, CT (US) 5,538,897 A 7/1996 Yates, III et al. s s 5,541,070 A 7/1996 Kauvar (73) Assignee: Life Technologies Corporation, .. S.E. al Carlsbad, CA (US) 5,585,069 A 12/1996 Zanzucchi et al. 5,585,639 A 12/1996 Dorsel et al. (*) Notice: Subject to any disclaimer, the term of this 5,593,838 A 1/1997 Zanzucchi et al. patent is extended or adjusted under 35 5,605,662 A 2f1997 Heller et al. U.S.C. 154(b) by 0 days. 5,620,850 A 4/1997 Bamdad et al. 5,624,711 A 4/1997 Sundberg et al. (21) Appl. No.: 10/865,431 5,627,369 A 5/1997 Vestal et al. 5,629,213 A 5/1997 Kornguth et al. (22) Filed: Jun. 9, 2004 (Continued) (65) Prior Publication Data FOREIGN PATENT DOCUMENTS US 2005/O118665 A1 Jun. 2, 2005 EP 596421 10, 1993 EP 0619321 12/1994 (51) Int. Cl. EP O664452 7, 1995 CI2O 1/50 (2006.01) EP O818467 1, 1998 (52) U.S.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2006/0068405 A1 Diber Et Al
    US 2006.0068405A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2006/0068405 A1 Diber et al. (43) Pub. Date: Mar. 30, 2006 (54) METHODS AND SYSTEMIS FOR Correspondence Address: ANNOTATING BOMOLECULAR Martin D. Moynihan SEQUENCES PRTSI, Inc. (76) Inventors: Alex Diber, Rishon-LeZion (IL); Sarah P.O. Box 16446 Pollock, Tel-Aviv (IL); Zurit Levine, Arlington, VA 22215 (US) Herzlia (IL); Sergey Nemzer, RaAnana (IL); Vladimir Grebinskiy, Highland Park, NJ (US); Brian Meloon, (21) Appl. No.: 11/043,860 Plainsboro, NJ (US); Andrew Olson, Northport, NY (US): Avi Rosenberg, Kfar Saba (IL); Ami Haviv, (22) Filed: Jan. 27, 2005 Hod-HaSharon (IL); Shaul Zevin, Mevaseret Zion (IL); Tomer Zekharia, Givataim (IL); Zipi Shaked, Tel-Aviv (IL); Moshe Olshansky, Haifa (IL); Related U.S. Application Data Ariel Farkash, Haifa (IL); Eyal Privman, Tel-Aviv (IL); Amit Novik, (60) Provisional application No. 60/539,129, filed on Jan. Beit-YeHoshua (IL); Naomi Keren, 27, 2004. Givat Shmuel (IL); Gad S. Cojocaru, Ramat-HaSharon (IL); Pinch as Akiva, Publication Classification Ramat-Gan (IL); Yossi Cohen, Surrey (GB); Ronen Shemesh, Modi In (IL); (51) Int. C. Osnat Sella-Tavor, Kfar-Kish (IL); CI2O I/68 (2006.01) Liat Mintz, East brunswick, NJ (US); G06F 9/00 (2006.01) Hanging Xie, Lambertville, NJ (US); Dvir Dahary, Tel-Aviv (IL); Erez (52) U.S. Cl. ................................................... 435/6; 702/20 Levanon, Petach-Tikva (IL); Shiri Freilich, Haifa (IL); Nili Beck, Kfar Saba (IL); Wei-Yong Zhu, Plainsboro, (57) ABSTRACT NJ (US); Alon Wasserman, New York, NY (US); Chen Chermesh, Mishmar HaShiva (IL); Idit Azar, Tel-Aviv (IL); Polypeptide sequences and polynucleotide sequences are Rotem Sorek, Rechovot (IL); Jeanne provided.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2012/0266329 A1 Mathur Et Al
    US 2012026.6329A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2012/0266329 A1 Mathur et al. (43) Pub. Date: Oct. 18, 2012 (54) NUCLEICACIDS AND PROTEINS AND CI2N 9/10 (2006.01) METHODS FOR MAKING AND USING THEMI CI2N 9/24 (2006.01) CI2N 9/02 (2006.01) (75) Inventors: Eric J. Mathur, Carlsbad, CA CI2N 9/06 (2006.01) (US); Cathy Chang, San Marcos, CI2P 2L/02 (2006.01) CA (US) CI2O I/04 (2006.01) CI2N 9/96 (2006.01) (73) Assignee: BP Corporation North America CI2N 5/82 (2006.01) Inc., Houston, TX (US) CI2N 15/53 (2006.01) CI2N IS/54 (2006.01) CI2N 15/57 2006.O1 (22) Filed: Feb. 20, 2012 CI2N IS/60 308: Related U.S. Application Data EN f :08: (62) Division of application No. 1 1/817,403, filed on May AOIH 5/00 (2006.01) 7, 2008, now Pat. No. 8,119,385, filed as application AOIH 5/10 (2006.01) No. PCT/US2006/007642 on Mar. 3, 2006. C07K I4/00 (2006.01) CI2N IS/II (2006.01) (60) Provisional application No. 60/658,984, filed on Mar. AOIH I/06 (2006.01) 4, 2005. CI2N 15/63 (2006.01) Publication Classification (52) U.S. Cl. ................... 800/293; 435/320.1; 435/252.3: 435/325; 435/254.11: 435/254.2:435/348; (51) Int. Cl. 435/419; 435/195; 435/196; 435/198: 435/233; CI2N 15/52 (2006.01) 435/201:435/232; 435/208; 435/227; 435/193; CI2N 15/85 (2006.01) 435/200; 435/189: 435/191: 435/69.1; 435/34; CI2N 5/86 (2006.01) 435/188:536/23.2; 435/468; 800/298; 800/320; CI2N 15/867 (2006.01) 800/317.2: 800/317.4: 800/320.3: 800/306; CI2N 5/864 (2006.01) 800/312 800/320.2: 800/317.3; 800/322; CI2N 5/8 (2006.01) 800/320.1; 530/350, 536/23.1: 800/278; 800/294 CI2N I/2 (2006.01) CI2N 5/10 (2006.01) (57) ABSTRACT CI2N L/15 (2006.01) CI2N I/19 (2006.01) The invention provides polypeptides, including enzymes, CI2N 9/14 (2006.01) structural proteins and binding proteins, polynucleotides CI2N 9/16 (2006.01) encoding these polypeptides, and methods of making and CI2N 9/20 (2006.01) using these polynucleotides and polypeptides.
    [Show full text]
  • All Enzymes in BRENDA™ the Comprehensive Enzyme Information System
    All enzymes in BRENDA™ The Comprehensive Enzyme Information System http://www.brenda-enzymes.org/index.php4?page=information/all_enzymes.php4 1.1.1.1 alcohol dehydrogenase 1.1.1.B1 D-arabitol-phosphate dehydrogenase 1.1.1.2 alcohol dehydrogenase (NADP+) 1.1.1.B3 (S)-specific secondary alcohol dehydrogenase 1.1.1.3 homoserine dehydrogenase 1.1.1.B4 (R)-specific secondary alcohol dehydrogenase 1.1.1.4 (R,R)-butanediol dehydrogenase 1.1.1.5 acetoin dehydrogenase 1.1.1.B5 NADP-retinol dehydrogenase 1.1.1.6 glycerol dehydrogenase 1.1.1.7 propanediol-phosphate dehydrogenase 1.1.1.8 glycerol-3-phosphate dehydrogenase (NAD+) 1.1.1.9 D-xylulose reductase 1.1.1.10 L-xylulose reductase 1.1.1.11 D-arabinitol 4-dehydrogenase 1.1.1.12 L-arabinitol 4-dehydrogenase 1.1.1.13 L-arabinitol 2-dehydrogenase 1.1.1.14 L-iditol 2-dehydrogenase 1.1.1.15 D-iditol 2-dehydrogenase 1.1.1.16 galactitol 2-dehydrogenase 1.1.1.17 mannitol-1-phosphate 5-dehydrogenase 1.1.1.18 inositol 2-dehydrogenase 1.1.1.19 glucuronate reductase 1.1.1.20 glucuronolactone reductase 1.1.1.21 aldehyde reductase 1.1.1.22 UDP-glucose 6-dehydrogenase 1.1.1.23 histidinol dehydrogenase 1.1.1.24 quinate dehydrogenase 1.1.1.25 shikimate dehydrogenase 1.1.1.26 glyoxylate reductase 1.1.1.27 L-lactate dehydrogenase 1.1.1.28 D-lactate dehydrogenase 1.1.1.29 glycerate dehydrogenase 1.1.1.30 3-hydroxybutyrate dehydrogenase 1.1.1.31 3-hydroxyisobutyrate dehydrogenase 1.1.1.32 mevaldate reductase 1.1.1.33 mevaldate reductase (NADPH) 1.1.1.34 hydroxymethylglutaryl-CoA reductase (NADPH) 1.1.1.35 3-hydroxyacyl-CoA
    [Show full text]
  • The Structural and Functional Study of the Human Mitochondrial Hsp60 Chaperonin in Neurodegenerative Diseases
    University of Texas at El Paso DigitalCommons@UTEP Open Access Theses & Dissertations 2018-01-01 The trS uctural And Functional Study Of The Human Mitochondrial Hsp60 Chaperonin In Neurodegenerative Diseases Jinliang Wang University of Texas at El Paso, [email protected] Follow this and additional works at: https://digitalcommons.utep.edu/open_etd Part of the Biochemistry Commons Recommended Citation Wang, Jinliang, "The trS uctural And Functional Study Of The umH an Mitochondrial Hsp60 Chaperonin In Neurodegenerative Diseases" (2018). Open Access Theses & Dissertations. 20. https://digitalcommons.utep.edu/open_etd/20 This is brought to you for free and open access by DigitalCommons@UTEP. It has been accepted for inclusion in Open Access Theses & Dissertations by an authorized administrator of DigitalCommons@UTEP. For more information, please contact [email protected]. THE STRUCTURAL AND FUNCTIONAL STUDY OF THE HUMAN MITOCHONDRIAL HSP60 CHAPERONIN IN NEURODEGENERATIVE DISEASES JINLIANG WANG Doctoral Program in Chemistry APPROVED: Ricardo A Bernal, Ph.D., Chair Chu Young Kim, Ph.D. Xiujun Li, Ph.D. Jianying Zhang, Ph.D. Sudheer Molugu, Ph.D. Jay M. Bhatt, Ph.D. Charles Ambler, Ph.D. Dean of the Graduate School Copyright © by Jinliang Wang 2018 Dedication This dissertation is dedicated to my teachers and my family. All my achievements would not have been reached without their support. THE STRUCTURAL AND FUNCTIONAL STUDY OF THE HUMAN MITOCHONDRIAL HSP60 CHAPERONIN IN NEURODEGENERATIVE DISEASES by JINLIANG WANG, MS DISSERTATION Presented to the Faculty of the Graduate School of The University of Texas at El Paso in Partial Fulfillment of the Requirements for the Degree of DOCTOR OF PHILOSOPHY Department of Chemistry and Biochemistry THE UNIVERSITY OF TEXAS AT EL PASO December 2018 Acknowledgements I would like to express my sincere gratitude to my advisor Dr.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2015/0240226A1 Mathur Et Al
    US 20150240226A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2015/0240226A1 Mathur et al. (43) Pub. Date: Aug. 27, 2015 (54) NUCLEICACIDS AND PROTEINS AND CI2N 9/16 (2006.01) METHODS FOR MAKING AND USING THEMI CI2N 9/02 (2006.01) CI2N 9/78 (2006.01) (71) Applicant: BP Corporation North America Inc., CI2N 9/12 (2006.01) Naperville, IL (US) CI2N 9/24 (2006.01) CI2O 1/02 (2006.01) (72) Inventors: Eric J. Mathur, San Diego, CA (US); CI2N 9/42 (2006.01) Cathy Chang, San Marcos, CA (US) (52) U.S. Cl. CPC. CI2N 9/88 (2013.01); C12O 1/02 (2013.01); (21) Appl. No.: 14/630,006 CI2O I/04 (2013.01): CI2N 9/80 (2013.01); CI2N 9/241.1 (2013.01); C12N 9/0065 (22) Filed: Feb. 24, 2015 (2013.01); C12N 9/2437 (2013.01); C12N 9/14 Related U.S. Application Data (2013.01); C12N 9/16 (2013.01); C12N 9/0061 (2013.01); C12N 9/78 (2013.01); C12N 9/0071 (62) Division of application No. 13/400,365, filed on Feb. (2013.01); C12N 9/1241 (2013.01): CI2N 20, 2012, now Pat. No. 8,962,800, which is a division 9/2482 (2013.01); C07K 2/00 (2013.01); C12Y of application No. 1 1/817,403, filed on May 7, 2008, 305/01004 (2013.01); C12Y 1 1 1/01016 now Pat. No. 8,119,385, filed as application No. PCT/ (2013.01); C12Y302/01004 (2013.01); C12Y US2006/007642 on Mar. 3, 2006.
    [Show full text]
  • ATP-Bound States of Groel Captured by Cryo-Electron Microscopy
    Cell, Vol. 107, 869–879, December 28, 2001, Copyright 2001 by Cell Press ATP-Bound States of GroEL Captured by Cryo-Electron Microscopy Neil A. Ranson,1,5 George W. Farr,2,3 characterized of which is the GroEL/GroES system in Alan M. Roseman,1,6 Brent Gowen,4,7 E. coli (Hartl, 1996; Ranson et al., 1998; Sigler et al., Wayne A. Fenton,3 Arthur L. Horwich,2,3 1998). The essential physiological role of chaperonins, and Helen R. Saibil1 together with the experimental accessibility of the GroE 1Department of Crystallography system, has stimulated intensive biochemical and theo- Birkbeck College London retical analysis. The resulting information may provide Malet Street a conceptual model for ring complexes which harness London WC1E 7HX the energy of nucleotide binding for many cellular func- United Kingdom tions. 2 Howard Hughes Medical Institute and The double-ring GroEL binds nonnative proteins in a 3 Department of Genetics central cavity, then mediates productive folding inside Yale School of Medicine a sequestered space formed when ATP and GroES bind New Haven, Connecticut 06510 to the same ring as polypeptide. Each GroEL subunit 4 Biochemistry Department comprises an equatorial, ATP binding domain joined by Imperial College a hinge region to a slender intermediate domain that in Exhibition Road turn has a hinge connection to an apical domain mediat- London SW7 2AY ing polypeptide binding (Braig et al., 1994). The two United Kingdom apposed rings of equatorial domains hold the cylindrical oligomer together through both intra- and inter-ring con- tacts. The cooperative binding of ATP to a GroEL ring allows Summary rapid binding of GroES to that ring, converting it from a polypeptide-accepting to a folding-active state.
    [Show full text]
  • Functional Residues in Proteins
    Journal of Amino Acids Functional Residues in Proteins Guest Editors: Shandar Ahmad, Jung-Ying Wang, Zulfiqar Ahmad, and Faizan Ahmad Functional Residues in Proteins Journal of Amino Acids Functional Residues in Proteins Guest Editors: Shandar Ahmad, Jung-Ying Wang, Zulfiqar Ahmad, and Faizan Ahmad Copyright © 2011 SAGE-Hindawi Access to Research. All rights reserved. This is a special issue published in volume 2011 of “Journal of Amino Acids.” All articles are open access articles distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Editorial Board Fernando Albericio, Spain Mario Herrera-Marschitz, Chile Vadim A. Soloshonok, USA Jordi Bella, UK Riccardo Ientile, Italy Imre Sovago, Hungary Simone Beninati, Italy Hieronim Jakubowski, USA Heather M. Wallace, UK Carlo Chiarla, Italy Madeleine M. Joullie, USA Peter W. Watt, UK Kuo-Chen Chou, USA Sambasivarao Kotha, India Robert Wolfe, USA Arthur Conigrave, Australia Rentala Madhubala, India Guoyao Wu, USA Arthur J. L. Cooper, USA Andrei Malkov, UK Andreas Wyttenbach, UK Zbigniew Czarnocki, Poland Yasufumi Ohfune, Japan Nigel Yarlett, USA Dorothy Gietzen, USA Norbert Sewald, Germany Axel G. Griesbeck, Germany H. S. Sharma, Sweden Contents Functional Residues in Proteins, Shandar Ahmad, Jung-Ying Wang, Zulfiqar Ahmad, and Faizan Ahmad Volume 2011, Article ID 606354, 1 page Small Changes Huge Impact: The Role of Protein Posttranslational Modifications in Cellular Homeostasis and Disease, Tejaswita M. Karve and Amrita K. Cheema Volume 2011, Article ID 207691, 13 pages Role of Charged Residues in the Catalytic Sites of Escherichia coli ATP Synthase,ZulfiqarAhmad, Florence Okafor, and Thomas F.
    [Show full text]